The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial

INTRODUCTION: The purpose of this study was to compare urate-lowering (UL) efficacy and safety of daily febuxostat and allopurinol in subjects with gout and serum urate (sUA) ≥ 8.0 mg/dL in a six-month trial. METHODS: Subjects (n = 2,269) were randomized to febuxostat 40 mg or 80 mg, or allopurinol...

詳細記述

保存先:
書誌詳細
主要な著者: Becker, Michael A, Schumacher, H Ralph, Espinoza, Luis R, Wells, Alvin F, MacDonald, Patricia, Lloyd, Eric, Lademacher, Christopher
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2010
主題:
Research article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC2888216/
https://ncbi.nlm.nih.gov/pubmed/20370912
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/ar2978
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料